BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 32614851)

  • 1. Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.
    Li W; He W; Zhou Y; Guo Y
    PLoS One; 2020; 15(7):e0234655. PubMed ID: 32614851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferred or immediate stent implantation for primary percutaneous coronary intervention: A meta-analysis of randomized trials.
    Mahmoud AN; Saad M; Elgendy AY; Mentias A; Elgendy IY
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):260-264. PubMed ID: 28799712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferred Versus Immediate Stenting in Patients With ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Qiao J; Pan L; Zhang B; Wang J; Zhao Y; Yang R; Du H; Jiang J; Jin C; Xiong E
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferred versus conventional stent implantation in patients with acute ST-segment elevation myocardial infarction: An updated meta-analysis of 10 studies.
    Lee JM; Rhee TM; Chang H; Ahn C; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY
    Int J Cardiol; 2017 Mar; 230():509-517. PubMed ID: 28057364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
    Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
    J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Selvaraj V; Chatterjee S; Hirai T; Abbott JD; Bavishi C
    Catheter Cardiovasc Interv; 2022 Dec; 100(7):1151-1158. PubMed ID: 36326115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    Vaidya SR; Qamar A; Arora S; Devarapally SR; Kondur A; Kaul P
    Coron Artery Dis; 2018 Mar; 29(2):151-160. PubMed ID: 29120880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis.
    Yang Y; George KC; Luo R; Cheng Y; Shang W; Ge S; Xu G
    BMC Nephrol; 2018 Dec; 19(1):374. PubMed ID: 30577763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials.
    Xu H; Zhang X; Li J; Liu H; Hu X; Yang J
    BMC Cardiovasc Disord; 2019 Apr; 19(1):91. PubMed ID: 31010423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
    Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
    BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferred vs Immediate Stenting in Primary Percutaneous Coronary Intervention: A Collaborative Meta-analysis of Randomized Trials With Cardiac Magnetic Resonance Imaging Data.
    Cassese S; Belle L; Ndrepepa G; Bosson JL; Fusaro M; Lønborg J; Ahtarovski KA; Kelbæk H; Fusaro M
    Can J Cardiol; 2018 Dec; 34(12):1573-1580. PubMed ID: 30527145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.
    Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN
    Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
    Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Chatterjee S; Kundu A; Mukherjee D; Sardar P; Mehran R; Bashir R; Giri J; Abbott JD
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):205-212. PubMed ID: 28112470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
    Carrick D; Oldroyd KG; McEntegart M; Haig C; Petrie MC; Eteiba H; Hood S; Owens C; Watkins S; Layland J; Lindsay M; Peat E; Rae A; Behan M; Sood A; Hillis WS; Mordi I; Mahrous A; Ahmed N; Wilson R; Lasalle L; Généreux P; Ford I; Berry C
    J Am Coll Cardiol; 2014 May; 63(20):2088-2098. PubMed ID: 24583294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.